SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Break Out The Bubbly: White Wine May Be Good For You, University of Connecticut School of Medicine
October 14, 2008
 · 
1 min read
Drug Development
Ginkgo Biloba Protects Brain From Stroke, Johns Hopkins University Study
October 13, 2008
 · 
1 min read
Drug Development
Ginkgo Extract Offers Promise To Cut Stroke Damage, Duke University Study
October 10, 2008
 · 
1 min read
Drug Development
New Method Generates Stem Cells Safely From Mice, Kyoto University Researchers Say
October 10, 2008
 · 
1 min read
Drug Development
Case Western Reserve University Research Finds Drug Candidate Slows Age-Related Macular Degeneration
October 10, 2008
 · 
1 min read
Drug Development
Prostate Cancer Biomarker Effectively Inhibits Pain, University of North Carolina At Chapel Hill School Of Medicine And University Of Helsinki
October 9, 2008
 · 
1 min read
Drug Development
Anti-Cancer Drug Prevents, Reverses Cardiovascular Damage In Mouse Model Of Premature Aging Disorder, National Institutes of Health (NIH) Reports
October 7, 2008
 · 
4 min read
Drug Development
DNA-based Vaccine Shows Promise Against Avian Flu, Rockefeller University Study
October 6, 2008
 · 
1 min read
Drug Development
New Approach To Gene Therapy May Shrink Brain Tumors, Prevent Their Spread, Massachusetts General Hospital Neuroscience Center Study
September 25, 2008
 · 
1 min read
Drug Development
Wine Ingredient Protects Against Radiation: University of Pittsburgh School of Medicine Report
September 23, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Catamaran Bio Presents Preclinical Data Supporting CAT-248, an Off-the-Shelf CD70-Targeted CAR-NK Cell Therapy for the Treatment of CD70-Expressing Cancers
December 13, 2021
 · 
4 min read
Drug Development
Q32 Bio Presents Preclinical Data Highlighting the Design and Characterization of Lead Program for Innate Immunity, ADX-097, at the 28th International Complement Virtual Workshop 2021
December 13, 2021
 · 
4 min read
Drug Development
Kura Oncology Reports Preclinical Data Highlighting Synergistic Activity of Menin Inhibitor KO-539 in Combination with Venetoclax
December 13, 2021
 · 
5 min read
Drug Development
OSE Immunotherapeutics Presents First Preclinical Efficacy Data on Anti-IL-7 Receptor Antagonist OSE-127 in Acute Lymphoblastic LeukemiaAt the 2021 American Society of Hematology (ASH) Annual Meeting
December 13, 2021
 · 
8 min read
Drug Development
Editas Medicine Reports Preclinical Data Demonstrating Robust Tumor Reduction and Clearance Using Novel, Engineered iNK Cells at the American Society of Hematology Annual Meeting
December 12, 2021
 · 
7 min read
Drug Development
Wugen Presents New Preclinical Data Supporting the Safety and Efficacy of WU-CART-007 for T-Cell Malignancies at the 63rd Annual Society of Hematology (ASH) Annual Meeting
December 12, 2021
 · 
3 min read
Drug Development
Nurix Therapeutics Announces Regulatory Clearance to Initiate Phase 1 Clinical Trial of NX-5948 and Presents New Preclinical Data at the American Society of Hematology Annual Meeting
December 12, 2021
 · 
6 min read
Drug Development
Neoleukin Therapeutics Announces Preclinical Data Highlighting Activity of NL-201 in Hematologic Malignancies at 63rd American Society of Hematology Annual Meeting (ASH 2021)
December 11, 2021
 · 
4 min read
Drug Development
Cellectis Reports Encouraging Clinical Data from BALLI-01 Study in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia, and Preclinical Data from TALGlobin01 at the 63rd American Society of Hematology Annual Meeting
December 11, 2021
 · 
9 min read
Drug Development
Ichnos Sciences Presents Preclinical Data On Novel ISB 1442 In Relapsed/Refractory Multiple Myeloma At The Ash 2021 Annual Meeting
December 11, 2021
 · 
4 min read
Drug Development
Epizyme Presents Preclinical Data and Phase 1/1b Trial Design on the Company’s SETD2 Inhibitor, EZM0414, at the 2021 ASH Annual Meeting
December 11, 2021
 · 
7 min read
Drug Development
Harpoon Therapeutics Presents Interim Clinical Data from its Ongoing Phase 1/2 Study and New Preclinical Results for BCMA-targeting TriTAC® HPN217 at the 63rd ASH Annual Meeting and Exposition
December 11, 2021
 · 
9 min read
Drug Development
Relay Therapeutics Announces Preclinical Data that Support Clinical Development of RLY-2608 as Both a Single Agent and in CombinationRLY-2608 combines with standard of care therapies to drive regressions in ER+/HER2- breast cancer models
December 10, 2021
 · 
7 min read
Drug Development
iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021
December 9, 2021
 · 
8 min read
Drug Development
Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021
December 9, 2021
 · 
8 min read
Drug Development
BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression
December 9, 2021
 · 
5 min read
Drug Development
Veru Announces Presentation of Preclinical Evidence Supporting the Therapeutic Benefit of Enobosarm Alone or in Synergistic Combination with a CDK4/6 Inhibitor Against Palbociclib Resistant Metastatic Breast Cancer
December 8, 2021
 · 
10 min read
Drug Development
PureTech Presents Preclinical Proof-of-Concept Data for LYT-300 (Oral Allopregnanolone) as Potential Treatment for Neurological and Neuropsychological Conditions
December 8, 2021
 · 
9 min read
Drug Development
Effort to repeat key cancer biology experiments reveals challenges and opportunities to improve replicability
December 7, 2021
 · 
8 min read
Drug Development
Specific Biologics Inc. Announces Therapeutic Development Award from the Cystic Fibrosis Foundation
December 7, 2021
 · 
2 min read
Load More